Eucalyptol - CAS:470-82-6

您当前的位置：

Eucalyptol (Synonyms:1,8-Cineole)

目录号 : KM17015 CAS No. : 470-82-6 纯度 : ≥98%

Data Sheet 产品使用指南

Eucalyptol 是 5-HT₃ 受体, 钾通道, TNF-α 和 IL-1β 的抑制剂。

规格	价格	是否有货
50mg		In-stock
100mg	询价	In-stock
200mg	询价	In-stock

加入购物车大包装询价

Other Forms of Rapamycin:

Ginkgolide J In-stock
Ginkgolide K In-stock
THK-5470 In-stock
NH-3 In-stock
Velufenacin In-stock

KKL Med 的所有产品和服务仅用于科学研究，不能被用于人体，兽医，我们也不向个人提供产品和服务。

生物活性

Eucalyptol is an inhibitor of 5-HT₃ receptor ,potassium channel, TNF-α and IL-1β.

体外研究

Eucalyptol inhibits 5-HT-evoked currents in oocytes expressing 5-HT₃ receptors with an IC₅₀ of 258 µM. Eucalyptol (Cin) treatment significantly decreases the ROS level in Aβ_25-35 treated cells in a dose dependent manner. Eucalyptol treatment significantly decreases the NO level in Aβ_25-35 treated cells in a dose dependent manner (p<0.05 and p<0.01). Eucalyptol treatment also significantly decreases IL-1βlevel in Aβ_25-35 treated cells in a dose dependent manner (p<0.05 and p<0.01) as compare to Aβ_25-35 treated PC12 cells. IL-6 level is also attenuated by Eucalyptol in dose dependent manner (p<0.05 and p<0.01) as compare to Aβ_25-35 treated cells.

体内研究

Results show that male and female rats treated with Eucalyptol (CIN) at the highest doses, 500 and 1000 mg/kg, have shown lower body weight than control group from the 7th to 50th day of treatment. The administration of Eucalyptol significantly reduces body weight gain of male rats (Eucalyptol 500 and 1000 mg/kg) and female rats (Eucalyptol 1000 mg/kg) in the first week of treatment. However, this reduction is followed by an increase in body weight of rats males and females treated with all doses of the second week until the end of treatment. For male rats, there is a significant increase of 6.93% in mean corpuscular volume (MCV) (Eucalyptol 1000 mg/kg) and of 43.54 and 38.98% in the platelet count (Eucalyptol 500 and 1000 mg/kg, respectively) and a decrease of 6.74 and 6.67% in mean corpuscular hemoglobin concentration (MCHC) (Eucalyptol 500 and 1000 mg/kg) and mean platelet volume (MPV) of 10.40, 10.60 and 15.73% (Eucalyptol 100, 500 and 1000 mg/kg, respectively), when compare to the control group.

分子式

C₁₀H₁₈O

分子量

154.25

CAS号

470-82-6

中文名称

桉油精；桉树脑

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Pure form	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶解性数据

In Vitro:

DMSO : ≥ 120 mg/mL (777.96 mM)

H₂O : 33.33 mg/mL (216.08 mM; Need ultrasonic)

* "≥" means soluble, but saturation unknown.

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	6.4830 mL	32.4149 mL	64.8298 mL
5 mM	1.2966 mL	6.4830 mL	12.9660 mL
10 mM	0.6483 mL	3.2415 mL	6.4830 mL

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用；以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

1.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline
Solubility: ≥ 3.5 mg/mL (22.69 mM); Clear solution

此方案可获得 ≥ 3.5 mg/mL (22.69 mM，饱和度未知) 的澄清溶液。
以 1 mL 工作液为例，取 100 μL 35.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。
2.

请依序添加每种溶剂： 10% DMSO 90% (20% SBE-β-CD in saline)
Solubility: ≥ 3.5 mg/mL (22.69 mM); Clear solution

此方案可获得 ≥ 3.5 mg/mL (22.69 mM，饱和度未知) 的澄清溶液。
以 1 mL 工作液为例，取 100 μL 35.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。
3.

请依序添加每种溶剂： 10% DMSO 90% corn oil
Solubility: ≥ 3.5 mg/mL (22.69 mM); Clear solution

此方案可获得 ≥ 3.5 mg/mL (22.69 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。
以 1 mL 工作液为例，取 100 μL 35.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。